Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

  1. Powles, T.
  2. Assaf, Z.J.
  3. Degaonkar, V.
  4. Grivas, P.
  5. Hussain, M.
  6. Oudard, S.
  7. Gschwend, J.E.
  8. Albers, P.
  9. Castellano, D.
  10. Nishiyama, H.
  11. Daneshmand, S.
  12. Sharma, S.
  13. Sethi, H.
  14. Aleshin, A.
  15. Shi, Y.
  16. Davarpanah, N.
  17. Carter, C.
  18. Bellmunt, J.
  19. Mariathasan, S.
Journal:
European Urology

ISSN: 1873-7560 0302-2838

Year of publication: 2023

Type: Article

DOI: 10.1016/J.EURURO.2023.06.007 GOOGLE SCHOLAR